Fractionated stereotactic radiotherapy in patients with acromegaly: An interim single-centre audit

European Journal of Endocrinology

Volumn 162, Issue 4, 2010, Pages 685-694

  Roug, S ^a   Rasmussen, A K ^a   Juhler, M ^a   Kosteljanetz, M ^a   Poulsgaard, L ^a   Heeboll H ^a   Roed, H ^a   Feldt Rasmussen, U ^a  

^a University of Copenhagen   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; SOMATOMEDIN C;

ACROMEGALY; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; FEMALE; FOLLOW UP; FRACTIONATED STEREOTACTIC RADIOTHERAPY; HUMAN; HYPOPHYSIS; MALE; MEDICAL AUDIT; NUCLEAR MAGNETIC RESONANCE IMAGING; ORAL GLUCOSE TOLERANCE TEST; PATIENT SAFETY; PRIORITY JOURNAL; REMISSION; RETROSPECTIVE STUDY; STEREOTACTIC TREATMENT; TRANSSPHENOIDAL SURGERY; TREATMENT OUTCOME;

ACROMEGALY; ADENOMA; ADULT; AGED; COHORT STUDIES; FEMALE; HUMAN GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PITUITARY NEOPLASMS; RETROSPECTIVE STUDIES;

EID: 77950305121     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-09-1045     Document Type: Article

References (42)

1. Ben-Shlomo A & Melmed S. Acromegaly. Endocrinology and Metabolism Clinics of North America 2008 37 101-122.
2. Holdaway IM. Excess mortality in acromegaly. Hormone Research 2007 68 166-172.
3. Monson JP. Is there still a role for radiotherapy in acromegaly? Neuroendocrinology 2006 83 269-273.
4. Freda PU. How effective are current therapies for acromegaly? Growth Hormone & IGF Research 2003 13 144-151.
5. Castinetti F, Morange I, Dufour H, Regis J & Brue T. Radiotherapy and radiosurgery in acromegaly. Pituitary 2009 12 3-10.
6. Shih HA & Loeffler JS. Radiation therapy in acromegaly. Reviews in Endocrine & Metabolic Disorders 2008 9 59-65.
7. Snead FE, Amdur RJ, Morris CG & Mendelhall WM. Long-term outcomes of radiotherapy for pituitary adenomas. International Journal of Radiation Oncology, Biology, Physics 2008 71 994-998.
8. Klose M, Lange M, Kosteljanetz M, Poulsgaard L & Feldt-Rasmussen U. Adrenocortical insufficiency after pituitary surgery: an audit of the reliability of the conventional short synacthen test. Clinical Endocrinology 2005 63 499-505.
9. Juul A, Bang P, Hertel NT, Main K, Dalgaard P, Jorgensen K, Muller J, Hall K & Skakkebaek NE. Serum insulin-like growth factor-I in 1030 healthy children, adolescents and adults: relation to age, sex, stage of puberty, testicular size and body mass index. Journal of Clinical Endocrinology and Metabolism 1994 78 744-752.
10. Minniti G, Jaffrain-Rea M-L, Osti M, Esposito V, Santoro A, Solda F, Gargiulo P, Tamburrano G & Enrici RM. The long-term efficacy of conventional radiotherapy in patients with GH-secreting pituitary adenomas. Clinical Endocrinology 2005 62 210-216.
11. Jenkins PJ, Bates P, Carson MN, Stewart PM & Wass JA. Conventional pituitary irradiation is effective in lowering serum growth hormone and insulin-like growth factor-I in patients with acromegaly. Journal of Clinical Endocrinology and Metabolism 2006 91 1239-1245.
12. Gutt B, Hatzach C, Morrison K, Pöllinger B & Schopohl J. Conventional pituitary irradiation is effective in normalising plasma IGF-I in patients with acromegaly. European Journal of Endocrinology 2001 144 109-116.
13. Selch MT, Gorgulho A, Lee SP, Mattozo C, Solberg TD, Agazaryan N & DeSalles AAF. Stereotactic radiotherapy for the treatment of pituitary adenomas. Minimally Invasive Neurosurgery 2006 49 150-155.
14. Minniti G, Traish D, Ashley S, Gonsalves A & Brada M. Fractionated stereo tactic conformal radiotherapy for secreting and nonsecreting pituitary adenomas. Clinical Endocrinology 2006 64 542-548.
15. Colin P, Jovenin N, Delemer B, Caron J, Grulet H, Hecart AC, Lukas C, Bazin A, Bernard MH, Scherpereel B, Peruzzi P, Nakib I, Redon C & Rousseaux P. Treatment of pituitary adenomas by fractionated stereo tactic radiotherapy: a prospective study of 110 patients. International Journal of Radiation Oncology, Biology, Physics 2005 62 333-341.
16. Milker-Zabel S, Zabel A, Huber P, Schlegel W, Wannenmacher M & Debus J. Stereotactic conformal radiotherapy in patients with growth hormone-secreting pituitary adenoma. International Journal of Radiation Oncology, Biology, Physics 2004 59 1088-1096.
17. Imran SA, Fleetwood IG, O'Connell CM, Ransom T, Mulroy LA, Ur E & Clarke DB. Outcome of stereotactic radiotherapy for patients with uncontrolled acromegaly. Canadian Journal of Neurological Sciences 2009 36 468-474.
18. Horvath E&Kovacs K. Pathologyof acromegaly. Neuroendocrinology 2006 83 161-165.
19. Colao A, Auriemma RS, Pivonello R, Galdiero M & Lombardi G. Medical consequences of acromegaly: what are the effects of biochemical control? Reviews in Endocrine & Metabolic Disorders 2008 9 21-31.
20. Roberts BK, Ouyang DL, Lad SP, Chang SD, Harch GR IV, Adler JR Jr, Soltys SG, Gibbs IC & Katznelson L. Efficacy and safety of CyberKnife radiosurgery for acromegaly. Pituitary 2007 10 19-25.
21. Mullan K, Sanabria C, Abram P, McConnell M, Courtney H, Hunter S, McCance D, Leslie H, Sheridan B & Atkinson B. Long term effect of external pituitary irradiation on IGF1 levels in patients with acromegaly free of adjunctive treatment. European Journal of Endocrinology 2009 161 547-551.
22. Brooke AM & Drake WM. Serum IGF-I in the diagnosis and monitoring of acromegaly. Pituitary 2007 10 173-179.
23. Clemmons DR. Clinical utility of measurements of insulin-like growth factor 1. Nature Clinical Practice. Endocrinology & Metabolism 2006 2 436-446.
24. Barkan AL. Radiotherapy in acromegaly: the argument against. Clinical Endocrinology 2003 58 132-135.
25. Hodish I & Barkan A. Long-term effects of pegvisomant in patients with acromegaly. Nature Clinical Practice. Endocrinology & Metabolism 2008 4 324-332.
26. Tzanela M. Dynamic tests and basal values for defining active acromegaly. Neuroendocrinology 2006 83 200-204.
27. Jørgensen JO, Feldt-Rasmussen UF, Andersen M, Kristensen LØ, Laurberg P & Weeke J. Acromegaly: new principles for treatment. Ugeskrift for Laeger 2007 169 905-906.
28. Colao A, Pivonello R, Cavallo LM, Gaccione M, Auriemma RS, Espositot F, Cappabianca P & Lombardi G. Age changes the diagnostic accuracy of mean profile and nadir growth hormone levels after oral glucose in postoperative patients with acromegaly Clinical Endocrinology 2006 65 250-256.
29. Espinosa-de-los-Monteros AL, Mercado M, Sosa E, Lizama O, Guinto G, Lopez-Felix B, Garcia O, Hernández I, Ovalle A & Mendoza V. Changing patterns of insulin-like growth factor-I and glucose-suppressed growth hormone levels after pituitary surgery in patients with acromegaly. Journal of Neurosurgery 2002 97 287-292.
30. Losa M, Gioia L, Picozzi P, Franzin A, Valle M, Giovanelli M & Mortini P. The role of stereotactic radiotherapy in patients with growth hormone-secreting pituitary adenoma. Journal of Clinical Endocrinology and Metabolism 2008 93 2546-2552.
31. Aghi M & Blevins LS Jr. Recent advances in the treatment of acromegaly. Current Opinion in Endocrinology, Diabetes and Obesity 2009 16 304-307.
32. Ronchi CL, Attanasio R, Verrua E, Cozzi R, Ferrante E, Loli P, Montefusco L, Motti E, Ferrari DI, Giugni E, Beck-Peccoz P & Arosio M. Efficacy and tolerability of gamma knife radiosurgery in acromegaly: a 10 year follow-up study. Clinical Endocrinology 2009 71 846-852.
33. Pollock BE. Stereotactic radiosurgery of benign intracranial tumors. Journal of Neuro-Oncology 2009 92 337-343.
34. Pollock BE, Brown PD, Nippoldt TB & Young WF. Pituitary tumor type affects the chance of biochemical remission after radiosurgery of hormone-secreting pituitary adenomas. Neurosurgery 2008 62 1271-1278.
35. Vik-Mo EO, Øksnes M, Pedersen P-H, Wentzel-Larsen T, Rødahl E, Thorsen F, Schreiner T, Aanderud S & Lund-Johansen M. Gamma knife stereotactic radiosurgery for acromegaly. European Journal of Endocrinology 2007 157 255-263.
36. Petit JH, Biller BMK, Coen JJ, Swearingen B, Ancukiewicz M, Bussiere M, Chapman P, Klibanski A & Loeffler JS. Proton stereotactic radiosurgery in management of persistent acromegaly. Endocrine Practice 2007 13 726-734.
37. Sword FM, Allan CA, Plowman PN, Sibtain A, Evanson J, Chew SL, Grossman AB, Besser GM & Monson JP. Stereotactic radiosurgery XVI: a treatment for previously irradiated pituitary adenomas. Journal of Clinical Endocrinology and Metabolism 2007 88 5334-5340.
38. Darzy KH & Shalet SM. Hypopituitarism following radiotherapy. Pituitary 2009 12 40-50.
39. Mondok À, Szeifert GT, Mayer À, Czirják S, Gláz E, Nyáry I & Rácz K. Treatment of pituitary tumours: radiation. Endocrine 2005 28 77-85.
40. Castinetti F, Nagai M, Morange I, Dufour H, Caron P, Chanson P, Cortet-Rudelli C, Kuhn JM, Conte-Devolx B, Regis J & Brue T. Long-term results of stereotactic radiosurgery in secretory pituitary adenomas. Journal of Clinical Endocrinology and Metabolism 2009 94 3400-3407.
41. Ayuk J & Stewart PM. Mortality following pituitary radiotherapy. Pituitary 2009 12 35-39.
42. Landolt AM, Haller D, Lomax N, Scheib S, Schubiger O, Siegfried J & Wellis G. Octreotide may act as a radioprotective agent in acromegaly. Journal of Clinical Endocrinology and Metabolism 2000 85 1287-1289.